Found: 13
Select item for more details and to access through your institution.
Recommendations for the optimal management of peritoneal metastases in patients with colorectal cancer: a TTD and GECOP-SEOQ expert consensus statement.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 12, p. 3378, doi. 10.1007/s12094-023-03204-7
- By:
- Publication type:
- Article
Interval cytoredutive surgery and HIPEC in advanced ovarian cancer with small-bowel disease: results and reflections.
- Published in:
- Clinical & Translational Oncology, 2022, v. 24, n. 8, p. 1542, doi. 10.1007/s12094-022-02795-x
- By:
- Publication type:
- Article
Acute renal disease in patients with ovarian peritoneal carcinomatosis treated with cytoreduction and HIPEC: the influence of surgery and the cytostatic agent used.
- Published in:
- Langenbeck's Archives of Surgery, 2021, v. 406, n. 7, p. 2449, doi. 10.1007/s00423-021-02279-6
- By:
- Publication type:
- Article
Usefulness of PIVKA-II for monitoring after liver transplantation in patients with hepatocellular carcinoma.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-32879-9
- By:
- Publication type:
- Article
Post-Publication Discussion Regarding Cytoreductive Surgery with or Without HIPEC After Neoadjuvant Chemotherapy in Ovarian Cancer.
- Published in:
- 2022
- By:
- Publication type:
- Letter
ASO Author Reflections: HIPEC with Cisplatin Improves Prognosis in Advanced Ovarian Cancer after Neoadjuvant Chemotherapy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 4, p. 2626, doi. 10.1245/s10434-021-11120-9
- By:
- Publication type:
- Article
ASO Visual Abstract: Cytoreductive Surgery with or Without HIPEC after Neoadjuvant Chemotherapy in Ovarian Cancer: A Phase III Clinical Trial.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
Cytoreductive Surgery With or Without HIPEC After Neoadjuvant Chemotherapy in Ovarian Cancer: A Phase 3 Clinical Trial.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 4, p. 2617, doi. 10.1245/s10434-021-11087-7
- By:
- Publication type:
- Article
HIPEC in Ovarian Cancer Is the Future... and Always Will Be? Results from a Spanish Multicentric Survey.
- Published in:
- Cancers, 2023, v. 15, n. 13, p. 3481, doi. 10.3390/cancers15133481
- By:
- Publication type:
- Article
Systematic Cholecystectomy During Cytoreductive Surgery Plus HIPEC: A Critical Analysis of an Empirical Tradition.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 10, p. 7157, doi. 10.1245/s10434-024-15863-z
- By:
- Publication type:
- Article
RETRACTED ARTICLE: Upfront citorreduction and hyperthermic intraperitoneal chemotherapy with paclitaxel in patients with stage III-C serous epithelial ovarian cancer.
- Published in:
- Clinical & Experimental Metastasis, 2021, v. 38, n. 2, p. 255, doi. 10.1007/s10585-019-10010-5
- By:
- Publication type:
- Article
Tako-tsubo syndrome after intraperitoneal hyperthermic chemotherapy (HIPEC) with cisplatin: an unusual complication of cytoreductive surgery plus HIPEC.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Peritoneal Surface Disease Severity Score (PSDSS), AGO-score and TIAN model in patients with platinum-sensitive recurrent ovarian cancer treated by cytoreductive surgery plus HIPEC.
- Published in:
- Clinical & Experimental Metastasis, 2019, v. 36, n. 5, p. 433, doi. 10.1007/s10585-019-09982-1
- By:
- Publication type:
- Article